DQX1

Model summary

An ATP-driven RNA-remodeling enzyme that assembles with ribonucleoprotein complexes to coordinate antiviral signaling and pre-mRNA splicing. Its helicase core and auxiliary RNA-binding modules enable high-affinity assembly with spliceosomal machinery and cytoplasmic RNA sensors, positioning it predominantly in the cytoplasm while dynamically engaging nuclear splicing assemblies. By reshaping RNA and scaffolding signaling-competent complexes, it enhances innate immune pathways initiated by cytosolic viral RNA detection and fine-tunes the downstream cascade.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The N-terminal two-thirds of the protein is encompassed by IPR027417 (P-loop containing nucleoside triphosphate hydrolase homologous superfamily, residues 12–550), establishing a RecA-like NTPase core that binds and hydrolyzes ATP. Nested within this core is IPR014001 (Helicase superfamily 1/2, ATP-binding domain, residues 33–238), which specifies a superfamily 1/2 helicase NTPase module that couples ATP hydrolysis to nucleic acid remodeling. Downstream, IPR007502 (Helicase-associated domain, residues 441–530) and its sub-architecture IPR048333 (Helicase-associated domain HA2, winged-helix, residues 442–470) provide an auxiliary RNA-binding and scaffolding platform that stabilizes ribonucleoprotein assemblies and positions the helicase relative to RNA substrates. The C-terminus carries IPR011709 (DEAD-box helicase, OB fold, residues 591–674), an OB-fold module that binds single-stranded RNA and coordinates interactions with spliceosomal and signaling complexes. The ordered layout—ATPase core (33–238) feeding into HA2/winged-helix (441–530) and terminating in an OB-fold (591–674)—creates a composite RNA remodeling machine that binds partners and remodels RNA-protein assemblies.

2. 02

   This architecture causes ATP-dependent RNA helicase activity and multivalent protein binding.

   The P-loop NTPase and SF1/2 ATP-binding domain (IPR027417 and IPR014001) supply the mechanochemical engine for unwinding or rearranging RNA duplexes, while the HA2 and OB-fold modules enforce high-affinity assembly with RNA and protein cofactors. These features justify GO:0005515 protein binding and further imply ATP-coupled RNA remodeling typical of DEAD-box/DEAD-like helicases.

3. 03

   From molecular function to process, the helicase scaffold is ideally suited to regulate antiviral RNA sensing and pre-mRNA splicing.

   The OB-fold and HA2 domains favor assembly into ribonucleoprotein machines, and this propensity aligns with participation in the catalytic step 2 spliceosome (GO:0071013). Spliceosome association explains how the protein can tune RNA maturation pathways that feed into innate immune signaling. In the cytoplasm, the same helicase core can expose or occlude viral RNA signatures, thereby modulating the RIG-I axis. This mechanistic coupling accounts for roles formalized as GO:0140374 antiviral innate immune response and GO:0039535 regulation of RIG-I signaling pathway. By remodeling RNA and assembling signaling-competent complexes, the helicase can enhance RIG-I pathway throughput, consistent with GO:0039533 positive regulation of RIG-I signaling pathway.

4. 04

   Cellular location follows from these assembly propensities.

   The absence of transmembrane segments and the presence of soluble helicase and OB-fold modules indicate a cytosolic enzyme that shuttles to nuclear RNP machineries. Its stable residence in spliceosomal assemblies (GO:0071013) and soluble pools supports a primary cytoplasmic localization with dynamic exchange to nuclear splicing compartments.

5. 05

   Mechanistically, I hypothesize that the helicase binds and remodels viral and host RNAs to control RIG-I access to pathogen-associated dsRNA and to coordinate downstream signaling nodes.

   In the nucleus, it associates with spliceosome components to regulate pre-mRNA processing; in the cytoplasm, it nucleates assemblies that potentiate RIG-I, MAVS, and TBK1/IKBKE signaling. Likely partners include RIG-I/DDX58, MAVS, TRIM25, and ubiquitin ligases that license RIG-I activation; and spliceosomal factors such as U2AF and SF3B modules that guide catalytic step 2. Together, the domain architecture and compartmental dynamics explain how an ATP-driven RNA helicase can both sculpt spliceosomal RNPs and amplify antiviral signaling through RIG-I pathway modulation.